BPC-157 and TB-500 in One Vial: 530 Daltons Apart
BPC-157 and TB-500 are co-formulated often enough that the pairing is treated as a single product. Analytically they are about as far apart as two peptides in one vial can be, and that turns out to be an advantage.
What is actually in the vial
Both blends hold the two compounds together, blended before lyophilisation, in equal proportions by mass. The 10 mg vial is 5 mg of each. The 20 mg vial is 10 mg of each. The number on the label is a sum, not the quantity of either component.
- BPC-157 — Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, C62H98N16O22, 1419.5 g/mol, CAS 137525-51-0.
- TB-500 — Ac-Leu-Lys-Lys-Thr-Glu-Thr-Gln, C38H68N10O14, 889.0 g/mol, CAS 885340-08-9.
TB-500 is the acetylated seven-residue fragment corresponding to the 17 to 23 region of thymosin beta-4, not the full 43-residue protein. That distinction is covered separately in thymosin beta-4 versus the TB-500 fragment.
530 daltons of separation
The two masses differ by roughly 530 daltons, which is a very comfortable margin. A singly protonated BPC-157 appears near m/z 1420.5 and a singly protonated TB-500 near m/z 890.0. The doubly charged ions at approximately 710.8 and 445.5 are equally distinct.
No resolution problem exists here. Any instrument capable of peptide work will report both components separately, and a spectrum of this blend showing only one mass is showing a problem rather than a limitation of the method.
They behave very differently on a column
BPC-157 is fifteen residues with three consecutive prolines, two aspartates and a glutamate. TB-500 is seven residues, acetylated at the N-terminus, carrying two lysines and one glutamate.
The shorter, more polar TB-500 generally elutes earlier under a standard water-acetonitrile gradient. The proline run in BPC-157 produces a characteristically broader peak, for reasons set out in the proline cis-trans article. A chromatogram of this blend therefore shows an early sharp peak and a later broader one, and that asymmetry in peak shape is expected rather than diagnostic of a problem.
Why area percentage does not give you the ratio
It is tempting to read the two peak areas and infer the mass ratio. That inference does not hold, because ultraviolet response at 214 nm scales with the number of peptide bonds, and BPC-157 has fourteen while TB-500 has six.
Equal masses of the two therefore do not produce equal peak areas. BPC-157 contributes more area per milligram, and a chromatogram of a genuine 50:50 blend shows the larger peptide over-represented. Converting area to mass requires response factors determined against reference standards for each component, which is a calibration exercise rather than an integration.
What a certificate for the blend should carry
Identity per component, not for the blend as a whole. A sequence, formula, mass and registry number for each, and a chromatogram in which both components are identified by retention against standards. A single purity percentage for a two-component vial is not a meaningful number, because the material is deliberately a mixture and the second peak is a specified constituent rather than an impurity.
The general case is set out in what one vial of several compounds can and cannot tell you.
Stability is set by the weaker component
A blend does not have its own stability profile; it inherits the shorter of its components’. Here both are reasonably robust. Neither contains cysteine or methionine, so the common oxidation routes are absent. BPC-157 carries two aspartates, which can cyclise to a succinimide and isomerise, and both carry glutamate and glutamine residues subject to slow deamidation.
Once reconstituted, the two share a solution, so any condition that degrades one is applied to both. Aliquoting and freezing rather than repeated vial entry is the usual precaution, described in aliquoting and vial entry.
You cannot separate them afterwards
The two are blended in solution before lyophilisation, which means the cake is a homogeneous mixture rather than two layers. There is no way to recover either component alone from a blended vial without a preparative separation.
Both compounds are stocked individually for that reason: BPC-157 and TB-500 are available as single-compound vials, and the blends are 10 mg total and 20 mg total.
What confirms a blend lot
Two masses, 1419.5 and 889.0, both observed. A chromatogram with both peaks assigned against reference standards. A stated composition in milligrams per component rather than a total alone. And no expectation that the peak areas will mirror the mass ratio, because they will not.
